US20180044673A1 - Methods for modulating mecp2 expression - Google Patents
US20120157333A1 - Oligonucleotides useful for detecting and analyzing nucleic acids of interest - Google Patents
WO2018172795A1 - MeCP2 EXPRESSION CASSETTES - Google Patents
WO2018172795A1 - MeCP2 EXPRESSION CASSETTES - Google Patents
WO2013173637A1 - Compositions and methods for modulating gene expression - Google Patents
WO2005013901A2 - Oligomeric compounds and compositions for use in modulation of small non-coding rnas - Google Patents
EP2023940B1 - Compounds and methods for modulating expression of sglt2 - Google Patents
Stem Cell-Derived Exosomes as New Horizon for Cell-Free Therapeutic Development: Current Status and Prospects
WO2020131862A1 - Crispr-associated transposase systems and methods of use thereof - Google Patents
Transcriptional Inhibition of the Mecp2 Promoter by MeCP2E1 and MeCP2E2 Isoforms Suggests Negative Auto-Regulatory Feedback that can be Moderated by Metformin
Mitochondrial modulation with leriglitazone as a potential treatment for Rett syndrome, Journal of Translational Medicine